Skip to main content

Advertisement

Log in

p53 codon 72 polymorphism and recurrent pregnancy loss: a meta-analysis

  • GENETICS
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Background

Arg72Pro polymorphism of the p53 tumour suppressor gene have been associated with recurrent pregnancy loss. However, results were inconsistent. We performed this metaanalysis to drive amore precise estimation of association between p53 codon 72 polymorphism and recurrent pregnancy loss.

Methods

Electronic searche of PubMed was conducted to select studies. Case-control studies containing available genotype frequencies of Arg72Pro were chose, and Odds ratio (OR) with 95% confidence interval (CI) was used to assess the strength of this association.

Results

4 case-control studies including 523 cases and 378controls were identified. This meta-analysis showed that individuals with the homozygous Pro/Pro genotype had increased risk of recurrent pregnancy loss (OR = 1.85, 95% CI: 1.078 ~ 3.173, p = 0.025) in the pooled analyses. An symmetric funnel plot, the Egger’s test (P = 0.497), and the Begg- test (P = 0.85) were all suggestive of the lack of publication bias.

Conclusion

This meta-analysis supports the idea that p53 condon72 Pro/Pro genotype is associated with increased risk of recurrent pregnancy loss. To draw comprehensive and true conclusions, further prospective studies with larger numbers of participants worldwide are needed to examine associations between p53 codon 72 polymorphism and recurrent pregnancy loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994;9:1328–32.

    PubMed  CAS  Google Scholar 

  2. Yamada H, Sata F, Saijo Y, Kishi R, Minakami H. Genetic factors in fetal growth restriction and miscarriage. Semin Thromb Hemost. 2005;31:334–45.

    Article  PubMed  CAS  Google Scholar 

  3. Sata F, Yamada H, Suzuki K, et al. Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss. Mol Hum Reprod. 2005;11:357–60.

    Article  PubMed  CAS  Google Scholar 

  4. Suryanarayana V, Deenadayal M, Singh L. Association of CYP1A1 gene polymorphism with recurrent pregnancy loss in the South Indian population. Hum Reprod. 2004;19:2648–52.

    Article  PubMed  CAS  Google Scholar 

  5. Sata F, Yamada H, Yamada A, et al. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss. Mol Hum Reprod. 2003;9:725–8.

    Article  PubMed  CAS  Google Scholar 

  6. Govindaiah V, Naushad SM, Prabhakara K, Krishna PC. Radha Rama Devi A. Association of parental hyperhomocysteinemia and C677T Methylene tetrahydrofolate reductase (MTHFR) polymorphism with recurrent pregnancy loss. Clin Biochem. 2009;42:380–6.

    Article  PubMed  CAS  Google Scholar 

  7. Kim SY, Park SY, Choi JW, et al. Association Between MTHFR 1298A > C Polymorphism and Spontaneous Abortion with Fetal Chromosomal Aneuploidy. Am J Reprod Immunol 2011.

  8. Makino A, Nakanishi T, Sugiura-Ogasawara M, Ozaki Y, Suzumori N, Suzumori K. No association of C677T methylenetetrahydrofolate reductase and an endothelial nitric oxide synthase polymorphism with recurrent pregnancy loss. Am J Reprod Immunol. 2004;52:60–6.

    Article  PubMed  Google Scholar 

  9. Choi HK, Choi BC, Lee SH, Kim JW, Cha KY, Baek KH. Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev. 2003;66:24–31.

    Article  PubMed  CAS  Google Scholar 

  10. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–10.

    Article  PubMed  CAS  Google Scholar 

  11. Li Z, Ni M, Li J, Zhang Y, Ouyang Q, Tang C. Decision making of the p53 network: Death by integration. J Theor Biol 2010.

  12. Brosh R, Rotter V. When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer. 2009;9:701–13.

    PubMed  CAS  Google Scholar 

  13. Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol. 1999;187:8–18.

    Article  PubMed  CAS  Google Scholar 

  14. Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000;14:34–44.

    PubMed  CAS  Google Scholar 

  15. Yuan A, Yu CJ, Luh KT, Kuo SH, Lee YC, Yang PC. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. J Clin Oncol. 2002;20:900–10.

    Article  PubMed  CAS  Google Scholar 

  16. Sivaraman L, Conneely OM, Medina D, O’Malley BW. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci U S A. 2001;98:12379–84.

    Article  PubMed  CAS  Google Scholar 

  17. Atwal GS, Bond GL, Metsuyanim S, et al. Haplotype structure and selection of the MDM2 oncogene in humans. Proc Natl Acad Sci U S A. 2007;104:4524–9.

    Article  PubMed  CAS  Google Scholar 

  18. Murphy ME. Polymorphic variants in the p53 pathway. Cell Death Differ. 2006;13:916–20.

    Article  PubMed  CAS  Google Scholar 

  19. Shi H, Tan SJ, Zhong H, et al. Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am J Hum Genet. 2009;84:534–41.

    Article  PubMed  CAS  Google Scholar 

  20. Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature. 2007;450:721–4.

    Article  PubMed  CAS  Google Scholar 

  21. Hu W, Feng Z, Atwal GS, Levine AJ. p53: a new player in reproduction. Cell Cycle. 2008;7:848–52.

    Article  PubMed  CAS  Google Scholar 

  22. Firouzabadi RD, Ghasemi N, Rozbahani MA, Tabibnejad N. Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss. Aust N Z J Obstet Gynaecol. 2009;49:216–9.

    Article  PubMed  Google Scholar 

  23. Coulam CB, Kay C, Jeyendran RS. Role of p53 codon 72 polymorphism in recurrent pregnancy loss. Reprod Biomed Online. 2006;12:378–82.

    Article  PubMed  CAS  Google Scholar 

  24. Kay C, Jeyendran RS, Coulam CB. p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. Reprod Biomed Online. 2006;13:492–6.

    Article  PubMed  CAS  Google Scholar 

  25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed  CAS  Google Scholar 

  27. Pietrowski D, Bettendorf H, Riener EK, et al. Recurrent pregnancy failure is associated with a polymorphism in the p53 tumour suppressor gene. Hum Reprod. 2005;20:848–51.

    Article  PubMed  CAS  Google Scholar 

  28. Kaare M, Butzow R, Ulander VM, Kaaja R, Aittomaki K, Painter JN. Study of p53 gene mutations and placental expression in recurrent miscarriage cases. Reprod Biomed Online. 2009;18:430–5.

    Article  PubMed  CAS  Google Scholar 

  29. Sjalander A, Birgander R, Kivela A, Beckman G. p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered. 1995;45:144–9.

    Article  PubMed  CAS  Google Scholar 

  30. Dumont P, Leu JI, Della Pietra 3rd AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65.

    Article  PubMed  CAS  Google Scholar 

  31. Sullivan A, Syed N, Gasco M, et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene. 2004;23:3328–37.

    Article  PubMed  CAS  Google Scholar 

  32. Bergamaschi D, Samuels Y, Sullivan A, et al. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet. 2006;38:1133–41.

    Article  PubMed  CAS  Google Scholar 

  33. Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer. 2004;108:196–9.

    Article  PubMed  CAS  Google Scholar 

  34. Kimber SJ. Leukaemia inhibitory factor in implantation and uterine biology. Reproduction. 2005;130:131–45.

    Article  PubMed  CAS  Google Scholar 

  35. Hambartsoumian E. Endometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation. Am J Reprod Immunol. 1998;39:137–43.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was financially supported by foundations (No. 30960152, No. 2008C043M, No. GREKF10-07).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ying Luo.

Additional information

Capsule

This meta-analysis showed that the Pro/Pro geotype had increased risk of recurrent pregnancy loss (RPL), suggests the p53 Arg72Pro polymorphism may be associated with RPL.

Wenru Tang and Xuhong Zhou contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tang, W., Zhou, X., Chan, Y. et al. p53 codon 72 polymorphism and recurrent pregnancy loss: a meta-analysis. J Assist Reprod Genet 28, 965–969 (2011). https://doi.org/10.1007/s10815-011-9618-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-011-9618-5

Keywords

Navigation